News & Updates

Show Multimedia Only
Ripretinib improves survival in advanced gastrointestinal stromal tumours

Ripretinib improves survival in advanced gastrointestinal stromal tumours

11 Apr 2023 byStephen Padilla

Treatment with ripretinib provides a prolonged clinical and radiological benefit in patients with advanced gastrointestinal stromal tumours (GIST) within the expanded access program (EAP) in the UK, as shown in a study presented at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

11 Apr 2023
Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery

Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery

09 Apr 2023

For patients with obesity and type 2 diabetes mellitus (T2DM) who are scheduled to undergo metabolic surgery, the presence of hypertension and hypercholesterolemia at baseline may predict failure of T2DM remission after the procedure, according to a study.

09 Apr 2023